Evidence map›Paper›PMID 40076792›Full record

ArticleInternational journal of molecular sciences2025

Molecular Mechanism of Vine Tea Dihydromyricetin Extract on Alleviating Glucolipid Metabolism Disorder in

Xixin Zhou, Xin Liu, Yuhang Yi, Shiyun Chen, Yi Zhang, Wei Fan, Chenghao Lv, Si Qin

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review of the Composition and Antimicrobial Roles of Extracts of Vine Tea (Ampelopsis grossedentata).Medical science monitor : international medical journal of experimental and clinical research · 2026
    Review
  2. Hepatoprotective action ofFrontiers in pharmacology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Xixin ZhouCollege of Bioscience and Biotechnology, Hunan Agricultural University, Changsha 410128, China.
Xin LiuCollege of Bioscience and Biotechnology, Hunan Agricultural University, Changsha 410128, China.
Yuhang YiCollege of Bioscience and Biotechnology, Hunan Agricultural University, Changsha 410128, China.
Shiyun ChenCollege of Food Science and Technology, Hunan Agricultural University, Changsha 410128, China.
Yi ZhangCollege of Bioscience and Biotechnology, Hunan Agricultural University, Changsha 410128, China.
Wei FanCollege of Food Science and Technology, Hunan Agricultural University, Changsha 410128, China.
Chenghao LvCollege of Bioscience and Biotechnology, Hunan Agricultural University, Changsha 410128, China.ORCID 0000-0002-1165-2720
Si QinCollege of Food Science and Technology, Hunan Agricultural University, Changsha 410128, China.ORCID 0000-0002-0788-2099

Funding

Changsha Natural Science Foundation kq2208076Hunan Natural Science Foundation No. 2023JJ30295
6 · The paper itself

Abstract

The primary active compound in vine tea is dihydromyricetin (DMY), which has a longstanding history as a dietary supplement and traditional ethnic medicine. However, the precise molecular mechanism by which vine tea dihydromyricetin extract (VDMY) regulates glucolipid metabolic disorder remains unclear. In this study, we first assessed the effect of VDMY on various physiological parameters in

Indexed as

FlavonolsLiverPlant ExtractsTeaAnimalsForkhead Box Protein O1Lipid MetabolismMaleMiceMice, Inbred C57BLMyeloid Differentiation Factor 88NF-kappa BRNA-SeqSignal TransductionToll-Like Receptor 4dihydromyricetinFlavonolsForkhead Box Protein O1Foxo1 protein, mouseMyd88 protein, mouseMyeloid Differentiation Factor 88NF-kappa BPlant ExtractsTeaTlr4 protein, mouseToll-Like Receptor 4dihydromyricetinglucolipid metabolic disorderRNA-seqTLR4/MyD88/NF-?B pathwayvine tea

Identifiers

PMID40076792
PMCPMC11900051

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.